Hemodynamic effects of the ketone body 3-hydroxybutyrate in a porcine acute pulmonary embolism model
Lise-Lotte Christensen(Aarhus University Hospital), Mads Dam Lyhne(Aarhus University Hospital), Kristoffer Berg‐Hansen(Aarhus University), Jacob Valentin Hansen(Aarhus University Hospital), Asger Andersen(Aarhus University Hospital), Nigopan Gopalasingam(Aarhus University Hospital), Jacob Marthinsen Seefeldt(Aarhus University), Roni Nielsen(Aarhus University), Ann Overgaard(Aarhus University Hospital), Casper Homilius(Aarhus University), O K H Oskar Kjaergaard Hoersdal(Aarhus University Hospital), Alexander Møller Larsen(Aarhus University), Simone Juel Dragsbæk(Aarhus University), Mark Stoltenberg Ellegaard(Aarhus University), Anders Kramer(Aarhus University Hospital)
Cited by 0
Related Papers
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
|European Journal of Heart Failure|2016|561
Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
|Circulation|2019|526
Ketone Body Infusion With 3‐Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study
|Journal of the American Heart Association|2017|235
Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure
|American Journal of Physiology-Heart and Circulatory Physiology|2010|165